Patent ID: 9642852
Date: 2017-05-09
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method for treating a disease or condition selected from the group consisting of cognitive impairment associated with schizophrenia, cognitive impairment, spasticity, anxiety disorder, alcoholism, pain, and cigarette dependence, said method comprising administering to a patient in need thereof an effective amount of a compound selected from the group consisting of: 6-(4,4-dimethylcyclohexyl)-4-[(1,1-dioxo-1λ trans-1-{[6-(4,4-dimethylcyclohexyl)-2-methylthieno[2,3-d]pyrimidin-4-yl]methyl}piperidine-3,4-diol, 1-{[6-(4,4-dimethylcyclohexyl)-2-methylthieno[2,3-d]pyrimidin-4-yl]methyl}piperidin-4-ol, 6-(4,4-dimethylcyclohexyl)-2-methyl-4-(thiomorpholin-4-ylmethyl)thieno[2,3-d]pyrimidine, 6-(4,4-dimethylcyclohexyl)-4-[(3,3-dimethylmorpholin-4-yl)methyl]-2-methylthieno[2,3-d]pyrimidine, and 1-{[6-(4,4-dimethylcyclohexyl)-2-methylthieno[2,3-d]pyrimidin-4-yl]methyl}-2,2-dimethylpiperidin-4-ol, or a salt of said compound.